Novo Holdings

cb Email

Status

ACTIVE

Global HQ

Hellerup, Denmark

Countries of investment

Denmark
United States
United Kingdom
China
India

Investment stages

Pre-Seed
Seed
Series A

Industries

Life Sciences
Biotechnology
Innovation

About
Novo Holdings is the sovereign investment arm of the Novo Nordisk Foundation, managing over €140 billion in assets aimed at generating long-term returns and positive societal impact through life sciences and diversified investments.

Min check size: $1M
Max check size: $10M
Fund size: Unlock
NPS: Unlock

Investment Thesis

Novo Holdings is the investment and holding arm of the Novo Nordisk Foundation, managing ~€142 billion in AUM and aiming to generate attractive long-term returns while driving positive societal impact. It allocates capital across two pillars. Life Science Investments (from seed to principal and planetary health stages) and diversified Capital Investments (public equities, real assets, fixed income), leveraging deep life-science expertise across all stages. The firm also champions sustainable and green-transition investments, exemplified by its landmark €16.5 billion acquisition of Catalent and funding of a quantum-tech hub in Denmark to support life-science innovation.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

Novo Holdings, the investment arm of the Novo Nordisk Foundation, represents one of Europe’s largest life sciences investment teams, managing assets of more than EUR 140 billion. Its venture division deploys around seven hundred million dollars annually into some sixty companies, guided by twenty-nine professionals based in Copenhagen, London, Boston, and San Francisco. This global scale, coupled with structured mentorship and senior oversight, reflects a management culture rooted in both stability and growth orientation.